Head to head for first-timers
CoreAge Rx vs Ozari Health
CoreAge Rx and Ozari Health both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxOzari Health
Rank #278 for first-timers · Grade C
Mama-Match
Best for: A budget that needs the lowest figure there is, setting the results claims entirely aside.
Visit Ozari HealthThe verdict for a first step
CoreAge Rx edges out Ozari Health on the Mama-Match Score, 94 to 41 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Ozari Health is still a genuine option — eighty-six dollars a month for compounded semaglutide is among the lowest anywhere on this page, and $125 for tirzepatide is genuinely cheap for the dual agonist. The problem sits right under those figures. Each card carries an average: "Average 15-20% body weight loss" on semaglutide and "Average 20-25%" on tirzepatide. The top of that second range is higher than tirzepatide achieved at its maximum dose in its own registrational trial, and these are compounded products that were never in it. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Ozari Health |
|---|---|---|
| Mama-Match Score | 94/100 · A | 41/100 · C |
| Overall rank | #1 | #278 |
| Semaglutide | $99/mo | From $86/mo |
| Tirzepatide | $149/mo | From $125/mo |
| Coverage | All 50 states | Not published on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Ozari Health
Rank #278 · Grade C
What we like
- Among the lowest published prices reviewed here for both molecules
- Prices each molecule separately rather than under one "starting at" figure
- Free discreet shipping included, and the dose described as physician-monitored
The caveats
- "Average 20-25% body weight loss" on the tirzepatide card exceeds what tirzepatide achieved at its highest dose in a controlled trial, and this is a compounded product
- "Average 15-20%" on the semaglutide card is likewise presented as an average rather than a trial ceiling
- Both prices say "starting at", so your dose may move them
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Ozari Health with the other providers we review for women.
Or browse the full comparison hub.